Literature DB >> 8235854

Sensitivity of Sickness Impact Profile items to measure change over time in a low-back pain patient group.

P Stratford1, P Solomon, J Binkley, E Finch, C Gill.   

Abstract

The purpose of this study was to identify Sickness Impact Profile (SIP) items that are most sensitive to change in patients with low-back pain. Seventy-six patients with low-back pain were administered the SIP at their initial visit and after discharge from physiotherapy treatment. A formal item reduction was performed to identify the most sensitive items. An item was considered sensitive if it showed change in 20% of the patients and had an item-corrected total SIP score correlation greater than 0.30. Twenty items were identified. Seven of the 20 items identified in this study appear on the Roland-Morris disability questionnaire. Also, only 50% of the items identified are from the physical subscale of the SIP.

Entities:  

Mesh:

Year:  1993        PMID: 8235854     DOI: 10.1097/00007632-199310000-00002

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Subjective outcome assessments for cervical spine pathology: A narrative review.

Authors:  Diane N Resnick
Journal:  J Chiropr Med       Date:  2005

2.  Smallest real difference, a link between reproducibility and responsiveness.

Authors:  H Beckerman; M E Roebroeck; G J Lankhorst; J G Becher; P D Bezemer; A L Verbeek
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  Sense of coherence and outcome of low-back surgery: 5-year follow-up of 80 patients.

Authors:  N Santavirta; H Björvell; Y T Konttinen; S Solovieva; M Poussa; S Santavirta
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

4.  Sense of coherence and outcome of anterior low-back fusion. A 5- to 13-year follow-up of 85 patients.

Authors:  N Santavirta; H Björvell; Y T Konttinen; S Solovieva; M Poussa; S Santavirta
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.